A comparative analysis of the long-term effects of cancer therapy on survivors enrolled in the UCCH Clinical Survivorship Registry: a cohort study

• Conditions: C00-C97; Malignant neoplasms

• Registration Number: DRKS00024951
• Lead Sponsor: niversitätsklinikum Hamburg-Eppendorf

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Completion: 2020-03-31
• Study Start: 2021-06-02
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 435

Inclusion Criteria

Patients with a history of cancer diagnosis who are undergoing follow-up and are currently tumor-free, patients who have completed tumor therapy or are in long-term maintenance therapy, age = 18 years, provided written informed consent.

Exclusion Criteria

Patients with a cancer diagnosis and are currently undergoing therapy, age < 18 years, or did not provide written informed consent.

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Impact of time since diagnosis on self-reported distress/anxiety/depression/fatigue.

Secondary Outcome Measures

Name	Time	Method
Impact of treatment modality/cancer diagnosis group/age on self-reported distress (NCCN DT), requirement of support (SCNS SF), anxiety (GAD-7), depression (PHQ-9) and fatigue (FACIT). The assessment of the questionnaires will be conducted within the survivorship councelling (week 0) and another time postal (week 24).